About
Metastat Inc (PINK:MTST) — investor relations, events, news, and company updates on 6ix.
Latest News
Jul 16 2018
MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations
Jun 21 2018
MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
Feb 28 2018
MetaStat Announces Positive Topline Data Showing Over 50% Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway
Sep 25 2017
MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations
Aug 3 2017
MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board
Financials
Revenue
$23.3 K
Market Cap
$3.53 K
EPS
-0.10
Google Übersetzer